Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines MPLT Q1 2026 Earnings EPS Miss of 20 Amid No Revenue Stock Declines HEPS Q1 2026 Earnings Loss per Share Widens as Stock Dips Nearly 4 SCCE Q1 2026 Earnings Massive EPS Miss Signals Operational Challenges FWDI Q1 2026 Earnings Strong EPS Beat Drives Profitability Despite Revenue Uncertainty SSC Technologies SSNC Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Market Reaction